drugset / Trial / NCT02525016

Safety Profile of IntRAvenous Lidocaine Use in Coelioscopic Bariatric Surgery

NCT02525016 ↗

Phase 3 Completed 50 enrolled Hospices Civils de Lyon
NaSingle-groupOpen-labelBasic science

Summary

Intravenous lidocaine is efficient for management of post operative pain in abdominal surgery. As previously published in literature the investigators use it during bariatric surgery. Nevertheless plasmatic concentration of lidocaine is unknown in this population, despite a widespread use. Investigators propose in this work to bring an objective proof that administration of lidocaine based on a modified body weight is safe. Intravenous administration concerned the peri operative period. A total of six samples are taken for each patient. Investigators get approbation of local ethic committee for this work.

Timeline

Start
2015-09
Primary completion
2016-05
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications